These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2156211

  • 1. Neuroblastoma: inverse relationship between expression of N-myc and NGF-r.
    Christiansen H, Christiansen NM, Wagner F, Altmannsberger M, Lampert F.
    Oncogene; 1990 Mar; 5(3):437-40. PubMed ID: 2156211
    [Abstract] [Full Text] [Related]

  • 2. Multiple defects of the nerve growth factor receptor in human neuroblastomas.
    Azar CG, Scavarda NJ, Reynolds CP, Brodeur GM.
    Cell Growth Differ; 1990 Sep; 1(9):421-8. PubMed ID: 1963076
    [Abstract] [Full Text] [Related]

  • 3. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P, Barbany G, Dominici C, Castello MA, Raschellá G, Persson H.
    Cancer Res; 1993 May 01; 53(9):2044-50. PubMed ID: 8481906
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.
    Reed JC, Meister L, Tanaka S, Cuddy M, Yum S, Geyer C, Pleasure D.
    Cancer Res; 1991 Dec 15; 51(24):6529-38. PubMed ID: 1742726
    [Abstract] [Full Text] [Related]

  • 5. Terminal differentiation in neuroblastoma cells transfected with the NGF receptor gene when treated with NGF.
    Matsushima H, Bogenmann E.
    Prog Clin Biol Res; 1991 Dec 15; 366():227-33. PubMed ID: 1648742
    [No Abstract] [Full Text] [Related]

  • 6. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
    Weidner U, Peter S, Strohmeyer T, Hussnätter R, Ackermann R, Sies H.
    Cancer Res; 1990 Aug 01; 50(15):4504-9. PubMed ID: 1973362
    [Abstract] [Full Text] [Related]

  • 7. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.
    N Engl J Med; 1993 Mar 25; 328(12):847-54. PubMed ID: 8441429
    [Abstract] [Full Text] [Related]

  • 8. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
    Nakagawara A, Kadomatsu K, Sato S, Kohno K, Takano H, Akazawa K, Nose Y, Kuwano M.
    Cancer Res; 1990 May 15; 50(10):3043-7. PubMed ID: 2185879
    [Abstract] [Full Text] [Related]

  • 9. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M, Janz I, Wintzer HO, Wagner E, Bauknecht T.
    Anticancer Res; 1989 May 15; 9(6):1537-47. PubMed ID: 2697181
    [Abstract] [Full Text] [Related]

  • 10. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B.
    Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135
    [Abstract] [Full Text] [Related]

  • 11. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
    Kogner P, Barbany G, Björk O, Castello MA, Donfrancesco A, Falkmer UG, Hedborg F, Kouvidou H, Persson H, Raschella G.
    Prog Clin Biol Res; 1994 Apr 15; 385():137-45. PubMed ID: 7972205
    [Abstract] [Full Text] [Related]

  • 12. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
    Matsunaga T, Takahashi H, Ohnuma N, Tanabe M, Yoshida H, Iwai J, Shirasawa H, Simizu B.
    Cancer Res; 1991 Jun 15; 51(12):3148-52. PubMed ID: 2039993
    [Abstract] [Full Text] [Related]

  • 13. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.
    Chen J, Chattopadhyay B, Venkatakrishnan G, Ross AH.
    Cell Growth Differ; 1990 Feb 15; 1(2):79-85. PubMed ID: 1964795
    [Abstract] [Full Text] [Related]

  • 14. Inverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastoma.
    Nakagawara A, Ikeda K, Higashi K, Sasazuki T.
    Surgery; 1990 Jan 15; 107(1):43-9. PubMed ID: 2404349
    [Abstract] [Full Text] [Related]

  • 15. Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome.
    Grady-Leopardi EF, Schwab M, Ablin AR, Rosenau W.
    Cancer Res; 1986 Jun 15; 46(6):3196-9. PubMed ID: 2421891
    [Abstract] [Full Text] [Related]

  • 16. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E, Peterson S, Maekawa K, Matsushima H.
    Oncogene; 1998 Nov 05; 17(18):2367-76. PubMed ID: 9811468
    [Abstract] [Full Text] [Related]

  • 17. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
    Lavenius E, Gestblom C, Johansson I, Nånberg E, Påhlman S.
    Cell Growth Differ; 1995 Jun 05; 6(6):727-36. PubMed ID: 7669728
    [Abstract] [Full Text] [Related]

  • 18. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennett RH, Rosen ST, DiGiuseppe JA, Brodeur GM.
    Oncogene; 1990 Dec 05; 5(12):1821-7. PubMed ID: 2284101
    [Abstract] [Full Text] [Related]

  • 19. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
    Trojanowska M, Wu LT, LeRoy EC.
    Oncogene; 1988 Oct 05; 3(4):477-81. PubMed ID: 3078955
    [Abstract] [Full Text] [Related]

  • 20. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
    Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD.
    Cancer Res; 1990 Apr 15; 50(8):2347-50. PubMed ID: 2180567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.